(Q34391770)

1 August 2017

1 reference

title

Positron emission tomography imaging in oncology (English)

1 reference

positron emission tomography

1 August 2017

main subject

1 reference

Delbeke D

1

1 reference

1 August 2017

Martin WH

series ordinal

2

1 reference

1 August 2017

publication date

1 September 2001

1 reference

Radiologic Clinics of North America

1 August 2017

published in

1 reference

1 August 2017

volume

39

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

883-917

1 reference

Metastases in carcinoma; analysis of 1000 autopsied cases

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Grading liposarcomas with PET using [18F]FDG

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Comparative diagnostic accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Image Fusion System Using PACS for MRI, CT, and PET Images

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Treatment of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Utility of PET in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Benign causes of 18-FDG uptake on whole body imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Pancreatic cancer detected by positron emission tomography with 18F-labelled deoxyglucose: method and first results.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

The Role of FDG-PET in the Preoperative Assessment of N-Staging in Head and Neck Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Improvement in staging of esophageal cancer with the addition of positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Early prediction of treatment outcome in head and neck cancer with 2-18FDG PET

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Experience with positron emission tomography (PET) scans in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Pancreatic adenocarcinoma: combination of MR imaging, MR angiography and MR cholangiopancreatography for the diagnosis and assessment of resectability

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

FDG-PET and CT in Evaluation of Chemotherapy in Advanced Head and Neck Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Positron emission tomography in the detection and management of metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Value of iterative reconstruction, attenuation correction, and image fusion in the interpretation of FDG PET images with an integrated dual-head coincidence camera and X-ray-based attenuation maps

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Evaluation of benign vs malignant hepatic lesions with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

The role of hybrid cameras in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Positron emission tomography for preoperative staging of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Comparison of 18FDG-PET with 131iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Characterization of adrenal masses using MR imaging with histopathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

FDG-PET evaluation of indeterminate pancreatic masses

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Is Useless for the Detection of Local Recurrence after Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Positron emission tomography in urological oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Effectiveness of positron emission tomography for the detection of melanoma metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG)

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Clinical Utility of FDG-PET in Detecting Head and Neck Tumors. A Comparison of Diagnostic Methods and Modalities

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Recurrent rectal cancer and scar: differentiation with PET and MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

FDG PET in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Detection of unknown occult primary tumors using positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Surveillance for recurrent head and neck cancer using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Role of Positron Emission Tomography in Staging Esophageal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

A comparative diagnostic study of head and neck nodal metastases using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Physicochemical Properties and Isoenzyme Composition of Hexokinase From Normal and Malignant Human Tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Extranodal malignant lymphoma: detection with FDG PET versus CT

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Technical details of intraoperative lymphatic mapping for early stage melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Positron emission tomography in the evaluation of the N0 neck

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Diagnostic value of positron emission tomography for detecting breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small-cell lung cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

An evaluation of FDG-PET in the detection and differentiation of thyroid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

The impact of FDG positron emission tomography imaging on the management of lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Integration of PET in Radiation Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Recurrence of colorectal tumors: PET evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Prediction of surgical resectability in patients with hepatic colorectal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Initial assessment of positron emission tomography for detection of nonpalpable regional lymphatic metastases in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Imaging of renal cancer using positron emission tomography with 2-deoxy-2-(18F)-fluoro-D-glucose: pilot animal and human studies

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Stockholm Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Imaging metastatic testicular germ cell tumours with 18FDG positron emission tomography: prospects for detection and management

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

Accuracy of FDG-PET in Gastric Cancer Preliminary Experience

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970319-5

7 January 2021

10.1016/S0033-8389(05)70319-5

Identifiers

DOI

1 reference

1 August 2017

1 reference